Nationally, the incidence rate of neonatal abstinence syndrome (NAS) has increased 5-fold from 2004 to 2014. Yes during that same period, Michigan experienced an 8-fold increase. Michigan rural communities face a higher incidence rate of NAS, far outpacing their urban counterparts. Although we have higher incidence rates for NAS in our rural communities, pregnant women with substance use disorders face major barriers to screening and treatment. Through the Center for Rural Behavioral Health & Addiction Studies, MI Babies Project with support from the Substance Abuse and Mental Health Services Administration (SAMHSA), Project ECHO (Extension for Community Health Outcomes) will help us bring expertise on perinatal substance use disorder to rural communities via this virtual telementoring program, bringing the right knowledge to the right place at the right time to improve access to treatment and reduce NAS.
Saginaw Valley State University is expanding access to Project ECHO learning opportunities in our region. The Perinatal Substance Use Disorder ECHO offers the latest information and case-based learning in perinatal substance use disorder and best practices in pharmacologic and non-pharmacologic treatment of substance use disorder in pregnancy. See the calendar of presentations for details on the upcoming topics.
Funding for this Perinatal Substance Use Disorder Project ECHO was made possible (in part) by grant number 1H79SP082471-01 from SAMHSA. The views expressed in written Project ECHO materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
Saginaw Valley State University Project ECHO for Perinatal Substance Use Disorder meets new DEA training requirements.
Date |
Subject |
Presenter |
April 10, 2024 |
4th Trimester |
Susan DeVuyst-Miller, PharmD, AE-C |
May 8, 2024 |
Substance Use Disorder in Pregnancy |
Kathleen Schachman, PhD, FNP-BC, PMHNP-BC, PPCNP-BC, FAANP |
June 12, 2024 |
Recovery Resources |
Trisha Longley, CPRC |
July 10, 2024 |
Trauma Informed Care in Pregnancy |
Sabrina Savage, LMSW, CAADC, DP-S, CCTP |
August 14, 2024 |
Medication for Perinatal Opioid Use Disorder- Part 1 |
William Morrone, DO, MPH, MS, FAOAAM, ASAM, FACOFP, DABAM, DAAPM |
September 11, 2024 |
Medication for Perinatal Opioid Use Disorder- Part 2 |
William Morrone, DO, MPH, MS, FAOAAM, ASAM, FACOFP, DABAM, DAAPM |
October 9, 2024 |
Alcohol Use During Pregnancy |
Kathleen Schachman, PhD, FNP-BC, PMHNP-BC, PPCNP-BC, FAANP |
November 13, 2024 |
Tobacco, Marijuana, and Vaping during pregnancy |
Carol Essenmacher, DNP, PMHCNS-BC |
December 11, 2024 |
Psychostimulants During Pregnancy |
Dr. Robert McMorrow, MD |
January 8, 2025 |
Neonatal Abstinence Syndrome (NAS)/ Neonatal Opioid Withdrawal Syndrome (NOWS) |
Dr. Jeffery Cooper, MD-Billings Clinic |
February 12, 2025 |
Licensure Legal Implications/Child Protective Services |
Trisha Charbonneau-Ivey, BA, MSHAL |
March 12, 2025 |
Breastfeeding & Bonding During Substance Use Treatment and Recovery |
Susan DeVuyst-Miller, PharmD, AE-C & Sabrina Savage, LMSW, CAADC, DP-S, CCTP |
April 9, 2025 |
The 4th Trimester |
Susan DeVuyst-Miller, PharmD, AE-C |
May 14, 2025 |
Perinatal Mood Disorders and Mental Health in Pregnancy |
Kathleen Schachman, PhD, FNP-BC, PMHNP-BC, PPCNP-BC, FAANP |
DO, MPH, MS, FAOAAM, ASAM, FACOFP, DABAM, DAAPM Addictionologist
Ph.D., FNP-BC, PMHNP-BC, PPCNP-BC, FAANP Psychiatric Mental Health Nurse Practitioner
LMSW, CAADC, DP-S, CCTP Substance Use Disorder Counselor
Pharm.D., AE-C Pharmacist
CADC Peer Recovery Support Specialist
Project ECHO
Gilbertson Hall - Atrium — Room 225
Monday - Friday — 8:00 - 4:30 PM
echo@svsu.edu
(989) 964-7161